Articles from Niki BioSolutions, Inc.

Niki BioSolutions to Participate in the Lytham Partners Fall 2026 Investor Conference

NEW HAVEN, CT and PRINCETON, NJ, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Niki BioSolutions, Inc. (NASDAQ: NIKI), a life sciences company focused on addressing unmet medical needs and providing high-quality genomic and biomarker testing solutions, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026.

By Niki BioSolutions, Inc. · Via GlobeNewswire · September 25, 2026

Niki BioSolutions Accelerates Its Alzheimer’s Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics

Advanced multi-omics data analysis and biostatistical expertise to sharpen target and biomarker decisions across the platform

By Niki BioSolutions, Inc. · Via GlobeNewswire · September 14, 2026

Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference

Live company presentation will take place on September 14 at 10:30 AM ET

By Niki BioSolutions, Inc. · Via GlobeNewswire · September 8, 2026

Niki BioSolutions Enters into Strategic Agreement to Provide APOE Testing Services for Progressive Medical Research (PMR)

Partnership Expands Access to Clinically Critical Genetic Testing in Support of Leading Research Programs

By Niki BioSolutions, Inc. · Via GlobeNewswire · July 23, 2026